Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Revenue from Contract with Customers - Additional Information (Details)

v3.25.4
Revenue from Contract with Customers - Additional Information (Details) - EUR (€)
€ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues € 1,186,282 € 1,104,036 € 1,085,354
Revenue that was included in contract liability 13,959 22,306 14,847
Goods and Services Transferred Over Time      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues 151,055 184,989 207,568
APAC      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues 101,479 96,235 102,901
North America      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues 362,062 308,948 317,536
South America      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues 32,399 31,022 30,870
EMEA      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues 690,342 667,830 634,047
Italy      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues 93,334 72,065 77,839
High-Value Solutions      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues 546,374 422,351 366,433
Other Containment and Delivery Solutions      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues 491,800 511,391 512,855
Revenue from Engineering      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues 148,108 170,294 206,066
Biopharmaceutical and Diagnostic Solutions      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues 1,038,174 933,742 879,288
Biopharmaceutical and Diagnostic Solutions | Goods and Services Transferred Over Time      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues 29,698 38,585 17,737
Biopharmaceutical and Diagnostic Solutions | APAC      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues 87,715 83,293 76,436
Biopharmaceutical and Diagnostic Solutions | North America      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues 335,404 267,520 253,870
Biopharmaceutical and Diagnostic Solutions | South America      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues 29,861 26,605 25,301
Biopharmaceutical and Diagnostic Solutions | EMEA      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues 585,194 556,324 523,681
Biopharmaceutical and Diagnostic Solutions | High-Value Solutions      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues 546,374 422,351 366,433
Biopharmaceutical and Diagnostic Solutions | Other Containment and Delivery Solutions      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues 491,800 511,391 512,855
Engineering      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues 148,108 170,294 206,066
Engineering | Goods and Services Transferred Over Time      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues 121,357 146,404 189,831
Engineering | APAC      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues 13,764 12,942 26,465
Engineering | North America      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues 26,658 41,429 63,666
Engineering | South America      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues 2,538 4,417 5,569
Engineering | EMEA      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues 105,148 111,506 110,366
Engineering | Revenue from Engineering      
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]      
Revenues € 148,108 € 170,294 € 206,066